DK2194968T3 - Lerbaseret, aromatiseret og terapeutisk sammensætning - Google Patents

Lerbaseret, aromatiseret og terapeutisk sammensætning

Info

Publication number
DK2194968T3
DK2194968T3 DK08843692.8T DK08843692T DK2194968T3 DK 2194968 T3 DK2194968 T3 DK 2194968T3 DK 08843692 T DK08843692 T DK 08843692T DK 2194968 T3 DK2194968 T3 DK 2194968T3
Authority
DK
Denmark
Prior art keywords
flavored
clay
therapeutic composition
therapeutic
composition
Prior art date
Application number
DK08843692.8T
Other languages
English (en)
Inventor
Jerome Barra
Hazif Denis Le
Original Assignee
Ipsen Pharma Sas
Firmenich & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsen Pharma Sas, Firmenich & Cie filed Critical Ipsen Pharma Sas
Application granted granted Critical
Publication of DK2194968T3 publication Critical patent/DK2194968T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
DK08843692.8T 2007-08-13 2008-08-12 Lerbaseret, aromatiseret og terapeutisk sammensætning DK2194968T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07291005A EP2025332A1 (fr) 2007-08-13 2007-08-13 Composition thérapeutique aromatisée à base d'argile
PCT/FR2008/001185 WO2009056703A1 (fr) 2007-08-13 2008-08-12 Composition thérapeutique aromatisée à base d'argile

Publications (1)

Publication Number Publication Date
DK2194968T3 true DK2194968T3 (da) 2013-09-02

Family

ID=39052728

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08843692.8T DK2194968T3 (da) 2007-08-13 2008-08-12 Lerbaseret, aromatiseret og terapeutisk sammensætning

Country Status (27)

Country Link
US (2) US20100159013A1 (da)
EP (3) EP2025332A1 (da)
JP (2) JP5670189B2 (da)
KR (2) KR101503957B1 (da)
CN (2) CN101778622A (da)
AR (2) AR067929A1 (da)
BR (1) BRPI0814979A2 (da)
CA (1) CA2696062C (da)
CL (1) CL2008002366A1 (da)
DK (1) DK2194968T3 (da)
EA (1) EA017118B1 (da)
ES (2) ES2421379T3 (da)
GE (1) GEP20125539B (da)
HK (2) HK1143956A1 (da)
HU (1) HUE029713T2 (da)
MA (1) MA31678B1 (da)
ME (1) ME00975B (da)
MX (1) MX2010001533A (da)
NO (1) NO20100114L (da)
PE (1) PE20090939A1 (da)
PL (2) PL2710998T3 (da)
PT (2) PT2194968E (da)
SA (1) SA08290496B1 (da)
TN (1) TN2010000058A1 (da)
TW (2) TWI511734B (da)
UA (1) UA97408C2 (da)
WO (1) WO2009056703A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2025332A1 (fr) * 2007-08-13 2009-02-18 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Composition thérapeutique aromatisée à base d'argile
FR2952814B1 (fr) * 2009-11-23 2013-07-19 Ephyla Sas Composition comprenant un complexe de phyllosilicates organiquement modifies generer des emulsions huile dans eau eventuellement a froid
US20130310732A1 (en) 2011-01-12 2013-11-21 Sooft Italia Spa Corneal delivery of cross-linking agents by iontophoresis for the treatment of keratoconus and related ophthalmic compositions
ITUA20162277A1 (it) * 2016-04-04 2017-10-04 Chemists Res Srl Composizione comprendente diosmectite
CN105902625A (zh) * 2016-05-26 2016-08-31 朱胜利 一种小儿止泻药的服用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707367A (en) * 1984-07-16 1987-11-17 Sunkist Growers, Inc. Solid essential oil flavor composition
AU4635285A (en) * 1984-07-16 1986-02-10 Sunkist Growers, Inc. Solid essential oil flavor composition and method of manufacture
JPH064530B2 (ja) * 1985-02-23 1994-01-19 日本化薬株式会社 親水性基剤
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
AU6701694A (en) * 1993-04-16 1994-11-08 Mccormick & Company, Inc. Encapsulation compositions
FR2770778B1 (fr) * 1997-11-12 2000-05-26 Investigations Therapeutiques Composition pour le traitement des gastro-enterites aigues, procede de fabrication de cette composition et solution de traitement obtenue a partir de cette composition
KR20030050958A (ko) * 2001-12-20 2003-06-25 송우영 디옥타헤드랄 스멕타이트를 유효성분으로 함유하는 항균성외용조성물
US8334007B2 (en) * 2003-03-19 2012-12-18 Firmenich Sa Continuous process for the incorporation of a flavor or fragrance ingredient or composition into a carbohydrate matrix
CN100340235C (zh) * 2004-05-21 2007-10-03 山东绿叶制药有限公司 蒙脱石分散片及其制备工艺
EP1627573A1 (en) * 2004-08-20 2006-02-22 Firmenich Sa A process for the incorporation of a flavor or fragrance ingredient or composition into a carbohydrate matrix
JP2006083071A (ja) * 2004-09-14 2006-03-30 Takasago Internatl Corp 香粧品用固形製剤
WO2007051427A1 (fr) * 2005-11-04 2007-05-10 Zhejiang Hailisheng Pharmaceutical Limited Co. Montmorillonite modifiee, son procede de preparation et ses utilisations
FR2901360A1 (fr) 2006-05-16 2007-11-23 Horiba Abx Sas Soc Par Actions Dispositif de conditionnement pour analyse biologique
EP2025332A1 (fr) * 2007-08-13 2009-02-18 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Composition thérapeutique aromatisée à base d'argile

Also Published As

Publication number Publication date
KR20140133617A (ko) 2014-11-19
EP2194968A1 (fr) 2010-06-16
CN101778622A (zh) 2010-07-14
NO20100114L (no) 2010-03-10
ME00975B (me) 2012-06-20
GEP20125539B (en) 2012-05-25
TWI511734B (zh) 2015-12-11
ES2582871T3 (es) 2016-09-15
EP2025332A1 (fr) 2009-02-18
US9056055B2 (en) 2015-06-16
CL2008002366A1 (es) 2009-05-29
PT2194968E (pt) 2013-07-25
CA2696062C (fr) 2017-09-05
TWI519303B (zh) 2016-02-01
JP2014208715A (ja) 2014-11-06
HK1143956A1 (en) 2011-01-21
TN2010000058A1 (fr) 2011-09-26
SA08290496B1 (ar) 2012-11-03
CA2696062A1 (fr) 2009-05-07
EP2710998B1 (fr) 2016-04-20
JP5670189B2 (ja) 2015-02-18
WO2009056703A1 (fr) 2009-05-07
US20140377354A1 (en) 2014-12-25
MX2010001533A (es) 2010-03-15
EP2194968B1 (fr) 2013-06-19
JP2010535852A (ja) 2010-11-25
EP2710998A1 (fr) 2014-03-26
UA97408C2 (ru) 2012-02-10
TW201509424A (zh) 2015-03-16
KR101503957B1 (ko) 2015-03-18
EA201070257A1 (ru) 2010-06-30
US20100159013A1 (en) 2010-06-24
ES2421379T3 (es) 2013-09-02
WO2009056703A8 (fr) 2010-03-04
CN104173371A (zh) 2014-12-03
EA017118B1 (ru) 2012-09-28
HK1196271A1 (zh) 2014-12-12
PT2710998T (pt) 2016-07-28
BRPI0814979A2 (pt) 2015-02-03
PL2710998T3 (pl) 2016-11-30
KR20100055460A (ko) 2010-05-26
TW200914034A (en) 2009-04-01
PL2194968T3 (pl) 2013-10-31
AR067929A1 (es) 2009-10-28
PE20090939A1 (es) 2009-07-27
HUE029713T2 (en) 2017-03-28
MA31678B1 (fr) 2010-09-01
AR114148A2 (es) 2020-07-29

Similar Documents

Publication Publication Date Title
DK2185164T3 (da) Sammensætning og terapeutisk antitumorvaccine
DK2049525T3 (da) N-laminoheteroaryl)-1H-indol-2-carboxamid-derivater, og fremstilling og terapeutisk anvendelse deraf
ATE525088T1 (de) Kombinationstherapie
CY2014030I1 (el) Θεραπευτικες συνθεσεις που περιλαμβανουν ingenol-3-angelate
DK1959991T3 (da) Terapeutisk vaccine
DE602006004866D1 (de) Katheter
DK1954140T3 (da) Glycerollevulinatketaler og deres anvendelse
DK1940467T3 (da) Lægemiddelsammensætning med langvarig frigivelse
BRPI0812562A2 (pt) composições terapêuticas anti-cd20 e métodos
DK3424932T3 (da) Bronophthalider til terapeutisk anvendelse
DK2107905T3 (da) Fast sammensætning omfattende alogliptin og pioglitazon
ATE467633T1 (de) 2-aryl-6-phenylimidazoä1,2-aüpyridin-derivate, ihre herstellung und therapeutische verwendung
DK2170827T3 (da) Indolin-2-oner og aza-indolin-2-oner
FR2887132B3 (fr) Matelas combine
DE602006018953D1 (de) Mammografiegerät
DK2079485T3 (da) Phenylpropionamidforbindelser og anvendelsen deraf
DK2185005T4 (da) Synergetisk sammensætning omfattende smagsstoffer og organiske syrer og anvendelse deraf
DK2001556T3 (da) Thioninium-forbindelser og anvendelse deraf
DK2035369T3 (da) Terapeutiske
DK2313404T3 (da) Quinuclidin-carbonat-derivater og medicinsk sammensætning deraf
DK2160336T3 (da) Forbindelsesmekanisme og fremgangsmåde
DK1885716T3 (da) Thiazolderivater og anvendelse deraf
DK2173831T3 (da) Brøndbehandling
BRPI0820410A2 (pt) Lactans substituídos terapêuticos
DK1773829T3 (da) Aminotropanderivater, fremstilling og terapeutiske anvendelser heraf